Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do?

Hyman, Phelps & McNamara (“HPM”) Director Larry Houck will present “Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do?” at this year’s American Pharmacists Association’s (“APhA’s”) Annual Meeting in Phoenix, March 24-27.  Mr. Houck was a diversion investigator with the Drug Enforcement Administration (“DEA”) in the field and at agency headquarters for 15 years before joining HPM in 2001.  Mr. Houck’s session will address pharmacists’ corresponding responsibility to identify and resolve controlled substance prescribing red flags and how to prepare for and manage DEA inspections.

The session will occur Friday, March 24th.  Pharmacists can earn 1 continuing practice education credit for attending this session.

Some of the additional APhA meeting sessions will include:

• Patient counseling
• Veterinary Basics for Community Pharmacists
• The ABCs of 340B
• Federal Regulation Affecting the Practice of Nuclear Pharmacy
• Pharmacy’s Impact on Disparities in Research
• Pharmacists and Patient-Centered Diabetes Care
• Updates in Alzheimer’s Disease
• Unique Patient Case Studies
• Taking the Sick Out of Sickle Cell Disease
• 2023 Immunization Update

Further meeting information, including registration, can be found here.